| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Pharmaceutical Sciences, St. Jude Childrens Research Hospital, Memphis, Tennessee 38105 [E. Y. K., N. F. K., W. E. E.]; University of Tennessee, Memphis, Tennessee 38163 [E. Y. K., N. F. K., W. E. E.]; and San Raffaele Scientific Insitute, via Olgettina 58, 20132 Milano, Italy [M. E. B.]
Thiopurine treatment of human leukemia cells deficient in components of the mismatch repair system (Nalm6) initiated apoptosis after incorporation into DNA, as revealed by caspase activation and terminal deoxynucleotidyl transferase-mediated nick end labeling assay. To elucidate the cellular sensor(s) responsible for recognition of DNA damage in cells with an inactive mismatch repair system, we isolated a multiprotein nuclear complex that preferentially binds DNA with thioguanine incorporated. The components of this nuclear multiprotein complex, as identified by protein mass spectroscopy, included high mobility group proteins 1 and 2 (HMGB1, HMGB2), heat shock protein HSC70, protein disulfide isomerase ERp60, and glyceraldehyde 3-phosphate dehydrogenase. The same complex was also shown to bind synthetic oligodeoxyribonucleotide duplexes containing the nonnatural nucleosides 1-ß-D-arabinofuranosylcytosine or 5-fluoro-2'-deoxyuridine. Fibroblast cell line derived from Hmgb1-/- murine embryos had decreased sensitivity to thiopurines, with an IC50 10-fold greater than Hmgb1-proficient cells (P < 0.0001) and exhibited comparable sensitivity to vincristine, a cytotoxic drug that is not incorporated into DNA. These findings indicate that the HMGB1-HMGB2-HSC70-ERp60-glyceraldehyde 3-phosphate dehydrogenase complex detects changes in DNA structure caused by incorporation of nonnatural nucleosides and is a determinant of cell sensitivity to such DNA modifying chemotherapy.
This article has been cited by other articles:
![]() |
M. Labazi, L. Jaafar, and H. Flores-Rozas Modulation of the DNA-binding activity of Saccharomyces cerevisiae MSH2-MSH6 complex by the high-mobility group protein NHP6A, in vitro Nucleic Acids Res., October 20, 2009; (2009) gkp649v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Phadke, N. F. Krynetskaia, A. K. Mishra, and E. Krynetskiy Glyceraldehyde 3-Phosphate Dehydrogenase Depletion Induces Cell Cycle Arrest and Resistance to Antimetabolites in Human Carcinoma Cell Lines J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 77 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Romesser, D. H. Perlman, D. V. Faller, C. E. Costello, M. E. McComb, and G. V. Denis Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma Am. J. Pathol., July 1, 2009; 175(1): 25 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mountassif, T. Baibai, L. Fourrat, A. Moutaouakkil, A. Iddar, M. S. El Kebbaj, and A. Soukri Immunoaffinity purification and characterization of glyceraldehyde-3-phosphate dehydrogenase from human erythrocytes Acta Biochim Biophys Sin, May 1, 2009; 41(5): 399 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Krynetskaia, M. S. Phadke, S. H. Jadhav, and E. Y. Krynetskiy Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage Mol. Cancer Ther., April 1, 2009; 8(4): 864 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Roemer, J. Adelman, M. E. A. Churchill, and D. P. Edwards Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding Nucleic Acids Res., June 1, 2008; 36(11): 3655 - 3666. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Krynetskaia, H. Xie, S. Vucetic, Z. Obradovic, and E. Krynetskiy High Mobility Group Protein B1 Is an Activator of Apoptotic Response to Antimetabolite Drugs Mol. Pharmacol., January 1, 2008; 73(1): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Annunziata, L. Kleinberg, B. Davidson, A. Berner, D. Gius, N. Tchabo, S. M. Steinberg, and E. C. Kohn BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6585 - 6592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grillo, C. D'Ambrosio, V. Consalvi, R. Chiaraluce, A. Scaloni, M. Maceroni, M. Eufemi, and F. Altieri DNA-binding Activity of the ERp57 C-terminal Domain Is Related to a Redox-dependent Conformational Change J. Biol. Chem., April 6, 2007; 282(14): 10299 - 10310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Earl, L. Yan, L. J. Vitone, J. Risk, S. J. Kemp, C. McFaul, J. P. Neoptolemos, W. Greenhalf, for the European Registry of Hereditary Pancreatit, R. Kress, et al. Evaluation of the 4q32-34 locus in European familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1948 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barker, M. Weinfeld, J. Zheng, L. Li, and D. Murray Identification of Mammalian Proteins Cross-linked to DNA by Ionizing Radiation J. Biol. Chem., October 7, 2005; 280(40): 33826 - 33838. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xing, J. R. LaPorte, J. K. Barbay, and A. G. Myers Identification of GAPDH as a protein target of the saframycin antiproliferative agents PNAS, April 20, 2004; 101(16): 5862 - 5866. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Brown, E. Y. Krynetski, N. F. Krynetskaia, D. Grieger, S. T. Mukatira, K. G. Murti, C. A. Slaughter, H.-W. Park, and W. E. Evans A Novel CRM1-mediated Nuclear Export Signal Governs Nuclear Accumulation of Glyceraldehyde-3-phosphate Dehydrogenase following Genotoxic Stress J. Biol. Chem., February 13, 2004; 279(7): 5984 - 5992. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Krynetskaia, T. L. Brenner, E. Y. Krynetski, W. Du, J. C. Panetta, P. Ching-Hon, and W. E. Evans Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-/- Mice Mol. Pharmacol., August 1, 2003; 64(2): 456 - 465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |